Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 5, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • The current Ebola Epidemic comes to an end

Addressing continued COVID-19 transmission despite universal masking

Nucleotide Excision Repair Factor-XPG

The current Ebola Epidemic comes to an end
  • BiotechToday
  • World

The current Ebola Epidemic comes to an end

BioTech Today June 21, 2021June 20, 2021

Soumya Shraddhya Paul, Amity University Noida

On Saturday, WHO official Alfred Ki-Zerbo declared the end of the current Ebola epidemic. After Guinea defeated the second Ebola outbreak that erupted in the West African states on February 14th, 2021 which infected around 16 people and claimed the life of 12, the second wave is reported to have been started from the forested Nzerekore region hailing in the southeast part of Guinea. The first Ebola outbreak came in 2014-2016, which killed around 11,300 people that mostly belong from the regions of Guinea, Sierra Leone, and Liberia. To control the spread of the Ebola epidemic Africa Centers for Disease Control and Prevention (Africa CDC) put on guidelines, enhanced cross-border surveillance along with that, they even did contact tracing. Health Minister Remy Lamah said in a press conference in Conakry “I solemnly declare the end of the Ebola outbreak in Guinea”.

What is Ebola?

The Ebola virus was first discovered in the year 1976 and was found near the Ebola River, which is currently in the Democratic Republic of Congo. Ebola virus belongs to a species of Zaire ebolavirus which causes Ebola virus disease (EVD) formerly known as Ebola hemorrhagic fever. It comes from the genus Ebolavirus which again has six species identified: Zaire, Bundibugyo, Sudan, Tai Forest, Reston, and Bombali. The virus causes severe bleeding, organ failure that can lead to death. Currently, EVD has a fatality rate of 50% and can be controlled by vaccination.

Ebola mostly spreads through direct contact i.e., through broken skin or mucous membranes, blood or body fluid, objects that have come in contact with the infected person through blood, feces, vomit, etc.

It was seen that health care workers were frequently affected by the virus due to their close contact with the infected person, during burial ceremonies the direct contact with the dead body also caused the virus to spread, it’s also important to note that pregnant women who recovered from EVD can also carry the virus in there breastmilk as well as the amniotic fluid which is unlike COVID.

What is an Epidemic and how did Western Africa win over it?

Epidemic refers to the outbreak of infectious diseases restricted to a particular geographical area like country or continent. Since Ebola was an infectious disease restricted to areas in the western part of the African continent, it is called an epidemic.

During the first wave of the epidemic, the Africa Centers for Disease Control and Prevention along with the World Health Organization (WHO) had put several relevant guidelines. These guidelines played a major role in containing the spread of the virus to other places in addition to a global spread of infection. WHO even shipped around 24,000 vaccine doses which inoculated 11,000 people as well as 2,800 frontline workers.

The vaccine used for Ebola is the attenuated recombinant vesicular stomatitis virus (rVSV) vaccine currently being manufactured by Merck.

USAID (United States Agency for International Development) also did a substantial amount of work by investing 2.4 billion dollars, Israel also contributed 8.75 million dollars to the United Nations (UN) Trust funds.

Contact tracing and fever surveillance along with safe burial practices majorly helped to contain the spread of the virus. People and the community worked together to sustain the virus especially since Africa is in major crises due to COVID as well.

In the end, we can conclude that as of now all the affected states have majorly won against the Ebola epidemic.

Also read: The fate of transplanted stem cell is unpredictable

References:

  1. https://www.hindustantimes.com/world-news/second-ebola-outbreak-officially-over-in-guinea-announces-who-101624102694348.html
  2. https://www.who.int/health-topics/ebola
  3. https://www.cdc.gov/vhf/ebola/history/summaries.html
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Africa Africa CDC contact tracing Ebola Ebola outbreak Ebolavirus epidemic Merck USAID vaccines WHO

2 thoughts on “The current Ebola Epidemic comes to an end”

  1. Pingback: Effect of yoga on Irisin hormone- the magic behind weight loss - BioXone
  2. Pingback: Trabecular bone texture analysis in assessing osteoarthritis - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Nucleotide Excision Repair Factor-XPG

bioxone June 21, 2021

Husna, Amity University Kolkata Nucleotide Excision Repair (NER) is a repair pathway of the genomic DNA. The genomic DNA can be damaged due to a variety of endogenous and environmental mutagens such as exposure of the skin cells to UV radiations from the sun. Such DNA damage can be repaired by the nucleotide excision repair […]

Nucleotide Excision Repair

Related Post

  • BiotechToday
  • India

Innovative Indian Ventilator Devices to tackle COVID-19

bioxone December 11, 2020December 10, 2020

Richismita Hazra, Amity University Kolkata The nationwide “Innovate2BeatCOVID” Grand Challenge has been won by three innovative ‘Ventilators and other respiratory Solutions’. This event was conducted by Marico innovation Foundation (MIF) and has awarded 85 lakhs in grants to the winners. These devices, made in India are affordable, disruptive and easily accessible. The use of best-in-class […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

ABCG2 contributes to multidrug resistance of cancer cells

BioTech Today June 22, 2021June 21, 2021

Saptaparna Pal, Amity University Kolkata The ATP binding cassette (ABC) transporter ABCG2, also known as breast cancer resistance protein is expressed in many tissues and tissue barriers, including blood-brain, blood-testis, and maternal-fetal barriers. It transports endogenous substrates such as estrone 3-sulfate and uric acid and also removes cytotoxic and endogenous compounds from cells. ABCG2 actively […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Are viral vaccines safe for children with an autoimmune disorder?

bioxone February 16, 2021February 16, 2021

Husna, Amity University Kolkata An autoimmune disease is a condition in which the immune system mistakenly attacks the healthy cells of the body. Children with autoimmune diseases often require treatment with immunosuppressive drugs. So, in these patients, the efficacy and safety of vaccination, particularly the live attenuated vaccines remain a concern.  As the live attenuated […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy